The principles of honest and mutually beneficial cooperation formed the foundation of our collaboration with Merz Pharma. Our companies were united by a common goal: to promote well-known treatments for soft tissue augmentation and botulinum toxin therapy, such as Radiesse, Belotero, Glytone and Xeomin, on the Russian market.
The IBSA pharmaceutical company, founded in 1945 by a group of Swiss biologists, is a leader in the production of treatments based on hyaluronic acid which are created using the latest technologies. All products are manufactured using state-of-the-art equipment and are subject to rigorous clinical trials. A comprehensive study of the role of hyaluronic acid in maintaining the normal state of the joints, respiratory system, and the skin prompted IBSA to create a new area of business: aesthetic dermatology. Today, the company produces a wide range of treatments designed to maintain the skin's health and beauty. The company places special emphasis on the production of highly purified, native hyaluronic acid, the main component of Viscoderm, Viscoderm Skinko, Viscoderm Pearls, Viscoderm Cream, Viscoderm Cover-Up, and Viscoderm Hydrogel Patch treatments, which are highly recommended in Russia; there have been no side effects associated with the use of these products.
InnoAesthetics (Spain) produces the Inno TDS, Inno-Roller, Inno-Exfo, Inno-Derma, and Inno-Caps, designed to solve a variety of aesthetic problems such as the treatment of hydro-lipodystrophy and excess fatty deposits, the complex correction and prevention of age-related skin changes on the face and body, and rehabilitation after invasive procedures. The medicinal products created using innovative technologies at the company's own pharmaceutical laboratory are notable for their high quality and the fact that they do not contain substances of animal origin and genetically modified components.
General Topics' roots can be traced back to the distant past. Way back in 1735, the ancestors of the company's founder, Doctor of Pharmacology Gianfranco de Paoli Ambrosi, opened the Farmacia de Paoli in the Italian city of Salo. It's hardly surprising that the company manages to successfully combine the use of modern technologies and also remain true to age-old traditions. Since its founding, the company regards scientific research and ground-breaking techniques to be of paramount importance. One of General Topics' strengths is the ability to use all the advantages of biological and technological methodology to fully unlock the potential of active ingredients. Among the products developed by General Topics available today in Russia are the Enerpeel non-invasive peels, the only products based on highly concentrated trichloroacetic acid (25% и 40%) and registered as medicinal products (product licence № FSZ 2009.04593, dated 25.06.2009). General Topics is also known for the cytoceuticals Tebiskin and Synchrovit, which are used in preparation for chemexfoliation, to speed up skin regeneration, and to strengthen the results achieved after a course of therapy.
Israeli company Venus Concept is creating revolutionary technologies and changing standards in aesthetic medicine. Experienced managers and researchers who are world-famous for their achievements are working at Venus Concept. Today, Venus Concept presented the Venus Freeze Plus apparatus in Russia. Venus Freeze Plus is the first system which combines the use of multipolar radio frequency and pulsed magnetic fields.
The German company Premium Aesthetics specialises in producing unique equipment and technologies in the field of aesthetic medicine. Today, Maruga introduces to Russia the onetec® high-frequency apparatus produced by Premium Aesthetics, intended for non-invasive anti-aging procedures and eliminating skin imperfections from the face and body. The apparatus is based on RWS (Radio Wave Spectrum) technology, a genuine breakthrough in cosmetology. RWS involves the use of specifically modulated high-frequency radiation, which allows for the coagulation of the blood vessels during couperosis, telangiectasia, and haemangioma. RWS makes it possible to perform ablation of pigmented areas, warts, fibroids and other neoplasms. RWS also enables skin tightening, even at the derma level, and allows for the painless removal of unwanted hair during epilation procedures.
Maruga is also the exclusive representative of the American dermatological company ZO Skin Health Inc., founded by Dr. Zein Obagi. The company produces two product lines: ZO Skin Health for everyday use and ZO Medical for correction of various pathological skin conditions. Doctor Obagi's success has served as an example for many companies but so far none of them have managed to repeat his achievements. The skincare system proposed by Zein Obagi can be characterised as “reasonable minimalism”; it involves the use of only those substances that are truly necessary to the skin in order to preserve its youth, beauty, and health for as long as possible.
For nearly 40 years, the laboratory specialists at TROLL COSMETICS have been searching for more and more efficient recipes for their own products. They develop each new formula in close collaboration with state-of-the-art scientific research institutes, clinics of aesthetic medicine and dermatology clinics. For their recipes, specialists choose exclusive raw materials that are biologically compatible with the skin. TROLL COSMETICS sets high standards in the development and manufacturing of DECLARE and JUVENA cosmetics for sensitive and mature skin. Today, both brands are featured in Maruga's portfolio of products.
MIRIAMQUEVEDO is a Spanish luxury brand of professional haircare products. MIRIAMQUEVEDO's office, research laboratory, and manufacturing plant are located in Barcelona. The company was named in honour of its founder, Miriam Quevedo, a dedicated, ambitious graduate of the University of Barcelona. All of this brand's cosmetics are of the absolute highest quality. MIRIAMQUEVEDO's formulas include natural ingredients with exceptional properties.
AstraZeneca is a leading innovative international biopharmaceutical company engaged in the study, development, production, and sale of prescription medications. Maruga collaborates with AstraZeneca on the drug EMLA, a local anaesthetic of the amide type.
At the heart of MIMESIS lies a desire: to shake up the rules. At the heart of MIMESIS lies a passion: for telling olfactory stories. At the heart of MIMESIS lies a mission: to bring back a long-forgotten, ancient tradition.
Founded in 2015 MIMESIS French Perfume House has already managed to create a grandiose furor by introducing something completely new that strikes the perfect balance between fragrance and hair care. The idea of perfume and hair care coming together in one product was embodied by two dedicated professionals - a true artist of perfumery Karine Dubreil and a scientist and exceptional formulator Catherine Taurin.
Mimesis product
portfolio includes selective fragrances and fragrant hair care products. Its
innovative formula enriched with patented active ingredient complex and natural
extracts effectively protects hair against damaging environmental influences
and offers a persistent scent. Rich perfumes tell real stories opening up its
notes pyramid gradually, moment by moment.
